Navigation Links
NIAID to convene HIV Vaccine Summit
Date:3/20/2008

What: On Tuesday, March 25, 2008, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will host an HIV Vaccine Summit in Bethesda, Md. as an important step in the ongoing process to examine the current direction of HIV vaccine research. Through interactive panel discussions, NIAID and the scientific community will explore

  • The optimal balance between vaccine discovery research and development studies designed to advance promising vaccine candidates into clinical trials

  • How to optimize and utilize non-human primate models to support vaccine research

  • How best to integrate clinical research with vaccine discovery efforts

Based on the panel discussions, NIAID is seeking specific recommendations on the types of research to foster and how to attract novel vaccine research ideas.

Media registration to attend the summit in-person has closed; however, media are invited to watch the summit during a live Webcast.

When: Tuesday, March 25, 2008 8:30 a.m. to 4:45 p.m. EST

Where: To view the online NIAID HIV Vaccine Webcast, go to: http://hivsummit.dgimeetingsupport.com. The View Webcast link will be live on March 25.

Contact: For more information, contact the NIAID Office of Communications at (301) 402-1663, niaidnews@niaid.nih.gov.


'/>"/>

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. NIAID scientists identify new cellular receptor for HIV
2. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
3. NIAID funds $51M contract to create comprehensive model of immune responses
4. Accordia Global Health Foundation Convenes Inaugural Infectious Diseases Summit
5. Specialists in drug discovery and development convene
6. International and Domestic Leaders to Convene to Tackle Health Issues in the Arab American Community
7. Healing Our Land, Inc. and The Massachusetts Black Legislative Caucus Convene Prevention Is Power Community Forum on the Impact of HIV/AIDS on Communities of Color in Massachusetts
8. Global Experts Convene to Discuss Emotional Trauma Caused by Disasters
9. National Business Coalition on Health Convenes Multi-Stakeholder Leadership Group to Address Value Based Purchasing Trends
10. Thought Leaders in Morbid Obesity Treatment Convene at Upcoming Surgical Conference
11. California Affiliates of Susan G. Komen for the Cure Convene Celebrities, Breast Cancer Survivors and Activists to Challenge Elected Officials to Strengthen Breast Cancer Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...g to two studies presented today, a nonsurgical tr... diseased thoracic aorta// offered patients less r...ortality rates when compared to surgery. During su... paraplegia because the thoracic aorta is clamped,...
... of existing research confirms that health-care wo...eatment if they are exposed// to HIV on the job. ... research into so-called occupational postexposure... what should be done when health-care workers are ...
... Food and Drug Administration (FDA) and the Center...inding consumers of the dangers of drinking milk t... Raw milk potentially contains a wide variety of ...:H7, Listeria, Campylobacter and Brucella – that m...
...n, the compound that gives red pepper its heat, co...boratory study.// If the results can be replicate...ngthening of capsaicin in the weight management su... by Euromonitor International to be worth US$0.93b...
Other Medicine News:Health News:Nonsurgical Thoracic Aorta Repair Has Much Less Risk of Paralysis Than Surgery 2Health News:Health-Care Workers Exposed to HIV on Job Need Preventive Treatment 2Health News:Health-Care Workers Exposed to HIV on Job Need Preventive Treatment 3Health News:FDA and CDC Remind Consumers of the Dangers of Drinking Raw Milk 2Health News:Chilli Extract may Stop Fat Cell Growth 2
(Date:10/6/2008)...6 Weeks of Radiation Therapy -, Event: Watch Singl...sday, October 22, 2008, 3 - 4 p.m. by visiting ...Va., Oct. 6 / Questions raced through...st cancer in May. Would she have the,tumor removed...otherapy?, , To view the Multimedia News Release...
(Date:10/6/2008)...mpany,s Bioabsorbable Stent - Also,Slated for Pres...ire/ -- Data from multiple clinical trials of,the ...us Bio-engineered R,stent, will be presented next ...ics symposium, TCT 2008, in Washington, D.C., Rob...al Center in,Amsterdam will provide a Genous clini...
(Date:10/5/2008)...urnal of Medicine reaffirm,well-established effica...iHaler(R), RIDGEFIELD, Conn., and NEW YORK, Oct. ...ding Potential Long-term Impacts on Function with,...er(R) (tiotropium bromide,inhalation powder), sust...ars as measured by FEV(1) (p<0.001) versus placebo...
(Date:10/3/2008)...rstCall/ -- Amsterdam Molecular,Therapeutics (Euro...erapy,announced today that it intends to incorpor...on Application (MAA) for Glybera(R) for Lipoprotei...ng and potentially lethal,disease., The data obta...,patients in total) demonstrate that Glybera(R) is...
Breaking Medicine Technology:Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 2AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 3Medline Receives Force Majeure Notice From Hong Ray Enterprises 23248 1Medline Receives Force Majeure Notice From Hong Ray Enterprises 23248 2UNICEF Ambassador Clay Aiken Visits North West Somalia 23246 1UNICEF Ambassador Clay Aiken Visits North West Somalia 23246 2UNICEF Ambassador Clay Aiken Visits North West Somalia 23246 3AVMA Collections Highlights Disaster Preparedness 23244 1AVMA Collections Highlights Disaster Preparedness 23244 2GeneraMedix Inc Receives Approval for Epoprostenol for Injection 1 5 mg 6376 1GeneraMedix Inc Receives Approval for Epoprostenol for Injection 1 5 mg 6376 2
...gulatory News-Ipsen,(Paris:IPN) announced today th... study for its investigational 4-month formulation...nable blood levels,of triptorelin for a duration o...ecided not to perform the second,administration as...been observed throughout the trial. At the end of ...
...re/ -- GlaxoSmithKline,plc announced results from ...nvestigational non-peptide oral platelet growth,fa... this study,showed that PROMACTA at 50-75mg once d...ase in platelet counts and also,reduced bleeding i...topenic purpura (ITP). These patients had previous...
Other Medicine Technology:Phase III Clinical Trial with 4-Month Long-Acting Formulation of,Triptorelin: Ipsen Decides Not to Perform Further Administration 2Phase III Clinical Trial with 4-Month Long-Acting Formulation of,Triptorelin: Ipsen Decides Not to Perform Further Administration 3Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 2Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 3Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 4Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 5Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 6
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: